Contezolid

Contezolid is an antibiotic of the oxazolidinone class. It is effective against Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, Streptococcus pyogenes, Streptococcus agalactiae, and other bacteria.
In 2021, it was approved by the National [Medical Products Administration] of China for the treatment of Skin and [skin structure infection|complicated skin and soft tissue infections].
A prodrug of contezolid, contezolid acefosamil, which is formulated for IV administration is in Phase III clinical trials for diabetic [foot infection].